102 related articles for article (PubMed ID: 10846560)
1. The relationship between the gene mutation of p53 and the protein expression of p53 and Ki-67 in non-Hodgkin's lymphomas.
Kuze T; Nakamura N; Hashimoto Y; Hojo H; Abe M; Wakasa H
Pathol Int; 1996 Feb; 46(2):130-6. PubMed ID: 10846560
[TBL] [Abstract][Full Text] [Related]
2. p53 protein expression in non-Hodgkin's lymphomas is infrequently related to p53 gene mutations.
Oka T; Sarker AB; Teramoto N; Yoshino T; Akagi T
Pathol Int; 1998 Jan; 48(1):15-21. PubMed ID: 9589459
[TBL] [Abstract][Full Text] [Related]
3. The expression of p53 protein in non-Hodgkin's lymphomas is not always dependent on p53 gene mutations.
Villuendas R; Piris MA; Algara P; Sánchez-Beato M; Sánchez-Verde L; Martinez JC; Orradre JL; García P; Lopez C; Martinez P
Blood; 1993 Nov; 82(10):3151-6. PubMed ID: 8219204
[TBL] [Abstract][Full Text] [Related]
4. P53 expression in Reed-Sternberg cells does not correlate with gene mutations in Hodgkin's disease.
Elenitoba-Johnson KS; Medeiros LJ; Khorsand J; King TC
Am J Clin Pathol; 1996 Dec; 106(6):728-38. PubMed ID: 8980348
[TBL] [Abstract][Full Text] [Related]
5. The pattern of p53 and p21WAF1/CIP1 immunoreactivity in non-Hodgkin's lymphomas predicts p53 gene status.
Mansukhani MM; Osborne BM; Zhong J; Matsushima AY
Diagn Mol Pathol; 1997 Aug; 6(4):222-8. PubMed ID: 9360843
[TBL] [Abstract][Full Text] [Related]
6. p53 protein over-expression and p53 gene abnormalities in HIV-1-related non-Hodgkin's lymphomas.
De Re V; Carbone A; De Vita S; Gloghini A; Maestro R; Gasparotto D; Vukosavljevic T; Boiocchi M
Int J Cancer; 1994 Mar; 56(5):662-7. PubMed ID: 8314342
[TBL] [Abstract][Full Text] [Related]
7. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
8. Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.
Petit B; Leroy K; Kanavaros P; Boulland ML; Druet-Cabanac M; Haioun C; Bordessoule D; Gaulard P
Hum Pathol; 2001 Feb; 32(2):196-204. PubMed ID: 11230707
[TBL] [Abstract][Full Text] [Related]
9. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.
Hernandez L; Fest T; Cazorla M; Teruya-Feldstein J; Bosch F; Peinado MA; Piris MA; Montserrat E; Cardesa A; Jaffe ES; Campo E; Raffeld M
Blood; 1996 Apr; 87(8):3351-9. PubMed ID: 8605352
[TBL] [Abstract][Full Text] [Related]
10. Post-thymic T cell lymphomas frequently overexpress p53 protein but infrequently exhibit p53 gene mutations.
Matsushima AY; Cesarman E; Chadburn A; Knowles DM
Am J Pathol; 1994 Mar; 144(3):573-84. PubMed ID: 8129043
[TBL] [Abstract][Full Text] [Related]
11. MDM2 overexpression does not account for stabilization of wild-type p53 protein in non-Hodgkin's lymphomas.
Maestro R; Gloghini A; Doglioni C; Gasparotto D; Vukosavljevic T; De Re V; Laurino L; Carbone A; Boiocchi M
Blood; 1995 Jun; 85(11):3239-46. PubMed ID: 7756655
[TBL] [Abstract][Full Text] [Related]
12. p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function.
Chilosi M; Doglioni C; Magalini A; Inghirami G; Krampera M; Nadali G; Rahal D; Pedron S; Benedetti A; Scardoni M; Macrì E; Lestani M; Menestrina F; Pizzolo G; Scarpa A
Blood; 1996 Nov; 88(10):4012-20. PubMed ID: 8916968
[TBL] [Abstract][Full Text] [Related]
13. p21WAF1/CIP1 and MDM2 expression in non-Hodgkin's lymphoma and their relationship to p53 status: a p53+, MDM2-, p21-immunophenotype associated with missense p53 mutations.
Villuendas R; Pezzella F; Gatter K; Algara P; Sánchez-Beato M; Martínez P; Martínez JC; Muñoz K; García P; Sánchez L; Kocialkowsky S; Campo E; Orradre JL; Piris MA
J Pathol; 1997 Jan; 181(1):51-61. PubMed ID: 9072003
[TBL] [Abstract][Full Text] [Related]
14. Correlation between mutations in p53 gene and protein expression in human lymphomas.
Martinez-Delgado B; Robledo M; Arranz E; Infantes F; Echezarreta G; Marcos B; Sanz C; Rivas C; Benitez J
Am J Hematol; 1997 May; 55(1):1-8. PubMed ID: 9136910
[TBL] [Abstract][Full Text] [Related]
15. Mutation of the p53 tumour suppressor gene and overexpression of its protein in 62 Japanese non-Hodgkin's lymphomas.
Kamata H; Mitani S; Fujiwara M; Aoki N; Okada S; Mori S
Clin Exp Med; 2007 Jun; 7(2):39-46. PubMed ID: 17609875
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
[TBL] [Abstract][Full Text] [Related]
17. Analysis of proliferating cell fraction determined by monoclonal antibody to M1-subunit ribonucleotide reductase and Ki-67 in relation to p53 protein expression in fine-needle aspirates from non-Hodgkin's lymphomas.
Sviatoha V; Tani E; Rassidakis G; Tribukait B; Kleina R; Skoog L
Cytopathology; 2000 Oct; 11(5):290-301. PubMed ID: 11014656
[TBL] [Abstract][Full Text] [Related]
18. p53 expression in lymphatic malignancies.
Soini Y; Pääkkö P; Alavaikko M; Vähäkangas K
J Clin Pathol; 1992 Nov; 45(11):1011-4. PubMed ID: 1452775
[TBL] [Abstract][Full Text] [Related]
19. [Value of protein 53 expression in lymphoma. Its correlation with genetic mutations].
Echezarreta G; Marcos B; Sanz C; Martínez B; Benítez J; Oliva H; Rivas C
Sangre (Barc); 1997 Oct; 42(5):369-75. PubMed ID: 9424736
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
